Bill
A 5566
Bill A 5566 mandates court consent before experimental drug testing on children in ACS care, ensuring their rights and safety in medical research.
Bill Number: A 5566
Title: Requires the commissioner of the administration of children's services to obtain an order of consent before allowing experimental drug testing on certain children
Status: Referred to Health
Introduced: February 14, 2025
Classification: Bill
Bill A 5566 aims to enhance the protection of children involved in experimental drug testing by mandating that the commissioner of the administration of children's services (ACS) must obtain a court order of consent prior to allowing any such testing on minors. This legislation seeks to ensure that the rights and welfare of vulnerable children are safeguarded in the context of medical research and experimentation.
Court Order Requirement: The bill stipulates that before any experimental drug testing can be conducted on children under the care of ACS, a court order of consent must be obtained. This requirement is designed to provide an additional layer of oversight and protection for children.
Scope of Application: The bill specifically targets children who are under the jurisdiction of the ACS, which includes those in foster care or other protective services.
Definition of Experimental Drug Testing: While the bill does not provide a detailed definition within the text, it implies that any drug testing that is not part of standard medical treatment would fall under this category.
Children in ACS Care: The primary group affected by this bill includes minors who are in the custody of the administration of children's services. These children may be involved in clinical trials or experimental treatments that could have significant health implications.
ACS and Medical Researchers: The ACS will need to adjust its protocols for approving participation in experimental drug testing, and medical researchers will need to navigate the legal requirements for obtaining consent.
Current Status: As of February 14, 2025, the bill has been referred to the Health Committee for further consideration. This step is crucial for the bill's advancement through the legislative process.
Related Legislation: The bill is part of a broader legislative context, with several related bills from prior sessions (A 5552, S 6481, S 4095, A 8573, A 3884) that may address similar issues regarding the rights of children in medical research.
Bill A 5566 represents a significant step towards ensuring that children involved in experimental drug testing are afforded necessary legal protections. By requiring a court order of consent, the bill aims to uphold the ethical standards of medical research and prioritize the safety and rights of minors in vulnerable situations. The bill is currently under review by the Health Committee, and its progress will be closely monitored by advocates for children's rights and health.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
